Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 300 publications
Executive Functioning, Attention Problems, and Social Impairments in Youth with Neurofibromatosis Type 1 and Autism Spectrum Disorder.
Journal: Journal of pediatric neuropsychology
Published: September 05, 2026
A Framework for Prioritizing Novel Agents in Malignant Peripheral Nerve Sheath Tumor Trials: A report from the Neurofibromatosis Clinical Trials Consortium.
Journal: Neuro-oncology
Published: May 13, 2026
MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors.
MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors.
Journal: Neuro-oncology advances
Published: April 30, 2026
Malignant peripheral nerve sheath tumor development during MEK inhibitor treatment: A pre-clinical study and a clinical case series.
Journal: Neuro-oncology advances
Published: April 27, 2026
Long-Term Hematologic Effects of Selumetinib Treatment in Children With Neurofibromatosis Type 1-Associated Plexiform Neurofibromas.
Journal: Pediatric blood & cancer
Published: April 02, 2026
Pharmacokinetics and Safety of Selumetinib Granule Formulation in Children With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas (SPRINKLE; phase I/II).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 27, 2026
Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade Glioma.
Journal: Neuro-oncology
Published: January 19, 2026
Tempered optimism: Advances in the precision medicine era for pediatric low-grade glioma.
Journal: Neuro-oncology
Published: January 19, 2026
NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.
Journal: Neurology
Published: December 30, 2025
Feasibility and Safety of High-Dose Proton Re-Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single-Institution Retrospective Study.
Journal: Pediatric blood & cancer
Published: December 16, 2025
Marrow-ablative chemotherapy and re-irradiation are associated with improved overall survival in patients with relapsed central nervous system nongerminomatous germ cell tumors.
Journal: Journal of neuro-oncology
Published: November 20, 2025
Last Updated: 09/26/2026